These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34583200)

  • 41. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimethylamine N-oxide-a marker for atherosclerotic vascular disease.
    Xie G; Yan A; Lin P; Wang Y; Guo L
    Rev Cardiovasc Med; 2021 Sep; 22(3):787-797. PubMed ID: 34565077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating Plasma Galectin-3 Levels in Patients With an Increased Risk of Atherosclerotic Cardiovascular Disease Who Underwent Coronary Artery Revascularization.
    Mayyas F; Ibrahim K
    Am J Cardiol; 2023 Sep; 203():73-80. PubMed ID: 37481815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of short-term popular diets on TMAO and other cardio-metabolic risk markers.
    Park JE; Miller M; Rhyne J; Wang Z; Hazen SL
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):513-517. PubMed ID: 30940489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
    Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
    ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
    Lever M; George PM; Slow S; Bellamy D; Young JM; Ho M; McEntyre CJ; Elmslie JL; Atkinson W; Molyneux SL; Troughton RW; Frampton CM; Richards AM; Chambers ST
    PLoS One; 2014; 9(12):e114969. PubMed ID: 25493436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of trimethylamine
    Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
    Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
    Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Eyileten C; Jarosz-Popek J; Jakubik D; Gasecka A; Wolska M; Ufnal M; Postula M; Toma A; Lang IM; Siller-Matula JM
    Front Cardiovasc Med; 2021; 8():728724. PubMed ID: 34778397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes.
    Kalagi NA; Thota RN; Stojanovski E; Alburikan KA; Garg ML
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.
    de Waha S; Jobs A; Eitel I; Pöss J; Stiermaier T; Meyer-Saraei R; Fuernau G; Zeymer U; Desch S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):28-37. PubMed ID: 28703046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
    Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease.
    Konieczny R; Żurawska-Płaksej E; Kaaz K; Czapor-Irzabek H; Bombała W; Mysiak A; Kuliczkowski W
    Cardiology; 2022; 147(4):443-452. PubMed ID: 35970148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
    Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted Plasma Metabolomics Reveals Association of Acute Myocardial Infarction Risk with the Dynamic Balance between Trimethylamine-
    Huang S; Lim SY; Tan SH; Chan MY; Ni W; Li SFY
    J Agric Food Chem; 2023 Oct; 71(41):15097-15105. PubMed ID: 37781984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Mortality Comparison of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated With Culprit-Only or Multivessel Percutaneous Coronary Intervention.
    Vergara R; Vignini E; Ciabatti M; Migliorini A; Valenti R; Antoniucci D
    Cardiovasc Revasc Med; 2021 Jan; 22():10-15. PubMed ID: 32605903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.
    Barrea L; Annunziata G; Muscogiuri G; Di Somma C; Laudisio D; Maisto M; de Alteriis G; Tenore GC; Colao A; Savastano S
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30551613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.